ShieldSkin™ Complex: Combating PM2.5 & Ozone-InducedSkin Oxidative Stress & Inflammation | High-Potency Antioxidant Actives(Fullerene, Ergothioneine) | Blue Eyes Biotech CO., Ltd.
Article Title:
ShieldSkin™ Complex: Combating PM2.5 & Ozone-InducedSkin Oxidative Stress & Inflammation | High-Potency Antioxidant Actives(Fullerene, Ergothioneine) | Blue Eyes Biotech CO., Ltd.
Detail Page Description:
Discover ShieldSkin™ Complex: Blue Eyes Biotech'sbreakthrough antioxidant formulation clinically proven to neutralize PM2.5& ozone-induced skin damage. Our synergistic blend of potent stabilizers(Fullerene C60, Ergothioneine) targets oxidative stress pathways &inflammatory cytokines, offering superior dermal protection. Ideal foranti-pollution skincare, nutraceuticals, & cosmeceuticals. Source premium,research-backed antioxidant raw materials. Request specs & formulations:[email protected] | www.blueeyes-bio.com
Environmental pollutants, particularlyPM2.5 and ground-level ozone, represent escalating threats to cutaneous health,driving premature aging through sustained oxidative stress and chronicinflammation. This study elucidates the dual mechanisms: 1) PM2.5 particlespenetrate skin barriers, generating free radicals via polycyclic aromatichydrocarbons (PAHs) and heavy metals, while 2) ozone depletes surfaceantioxidants, triggering lipid peroxidation cascades and NF-κB-mediatedpro-inflammatory cytokine release (IL-1α, IL-6, TNF-α). To counteract theseinsults, Blue Eyes Biotech developed ShieldSkin™ Complex – a synergisticantioxidant system featuring ultra-stable Fullerene (C60) and the potentbiological protector Ergothioneine (EGT). Fullerene’s exceptional electronaffinity scavenges multiple radicals per molecule, preventing mitochondrial DNAdamage. Ergothioneine, a naturally occurring thiourea derivative with specificcellular transporters, quenches singlet oxygen and inhibits NLRP3 inflammasome activation.In vitro human skin model testing confirmed ShieldSkin™'s efficacy:pre-treatment reduced ROS generation by 89% (±3.2%) post-PM2.5 exposure andsuppressed ozone-induced COX-2 expression by 76% (±5.1%) versus controls.Clinical assessments demonstrated significant (p<0.01) improvements inbarrier integrity (TEWL reduction ≥22%) and decreased inflammatory biomarkers (IL-8 ↓43%) in polluted urbanenvironments. As a premier supplier of high-purity plant-derived actives andcosmetic-grade antioxidants, Blue Eyes Biotech offers ShieldSkin™ as acustomizable, stable complex for integration into anti-pollution serums,protective day creams, nutraceutical capsules, and pharmaceutical barriercreams. Our technical dossier includes stability data, recommended usage levels(0.5-2%), and compatibility profiles. Partner with us for scientificallyvalidated, market-ready solutions against environmental skin aggressors. Sourcepremium ingredients: [email protected] | www.blueeyes-bio.com
